• PDF / 185,945 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 39 Downloads / 269 Views

DOWNLOAD

REPORT

1173-5503/20/0861-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 5 Sep 2020 No. 861

1

Recommend Documents

Semaglutide cost effective versus dulaglutide in Japan

170 20 182KB

Heplisav-B cost effective versus Engerix-B

168 82 166KB

Gender-neutral HPV vaccination cost effective versus girls-only

173 83 169KB

Cost-Effective

168 109 57MB

Atorvastatin cost effective in T2DM

163 57 182KB

Atomoxetine cost-effective in ADHD

158 88 139KB

Highly Cost-Effective Intervention

195 83 57MB

Trastuzumab cost effective in early breast cancer

115 43 122KB

Double CBT cost effective in acute leukaemia

157 46 115KB

Bevacizumab + capecitabine not cost effective in mCRC

162 48 111KB

Preoperative lymphoscintigraphy cost effective in vulvar cancer

157 31 166KB

Inhaled insulin cost effective in uncontrolled diabetes

170 91 119KB